Global Single-Cell Multi-Omics Market to Reach $3.18 Billion by 2025

The premium market intelligence report published by BIS Research on the title Global Single-Cell Multi-Omics Market highlights that the market is projected to reach $3.18 billion by 2025. The study also highlights that the market is set to witness a CAGR of 21.16% during the period between 2020 and 2025. The growth is aided by factors including increasing utilization of single-cell RNA sequencing for various cancer research.

The single-cell multi-omics approach enables integrating different molecules and analyzing them. This further has enabled to provide multi-faceted information on the characteristics of different omics layers. The information can then be used for diagnosis and drug-modification purposes. Through the advances in single-cell analysis assays, information on the genotypic and phenotypic traits could be revealed along with the regulatory mechanism of the cell at a single-cell resolution.

Browse 14 Market Data Tables and 167 Figures spread through 228 Pages and in-depth TOC on "Global Single-Cell Multi-Omics Market"

The comprehensive study covers the following:• Market numbers on micro-segments that are influencing the market? • More than 300 products present in the market • Market share analysis for more than 15 companies • End-user preference data for over 20 end users • Detailed global and regional market share analysis including the scrutiny of more than 15 countries?? • Study of data of more than 30 companies

Who Should Buy This Report?• Manufacturers of sequencing instruments, kits, assays, and consumables• Manufacturers of imaging instruments, kits, assays, and consumables• Companies involved in drug manufacturing and diagnostics development• Companies in the services market such as contract research organization• Companies involved in the development of solutions based on immunohistochemistry, fluorescent conjugated antibodies• Companies involved in developing bioinformatics tools for single-cell data analysis, visualization, sharing, and storage

To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include end user and market share analysis, types of products offered, type of omics, sample type, application, and region. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study.

View the Report from BIS Research: https://bisresearch.com/industry-report/global-single-cell-multi-omics-market.html

The premium market intelligence by BIS Research additionally throws a spotlight on the opportunities existing in the market, including the high scope for adoption of genomic-based medicine in emerging nations, increased use of single-cell technology solutions for the development of therapeutics drugs and comprehensive treatment plan, and requirement for the development of advanced solutions based on single-cell technology, among others.

The end user and pricing analysis of the global market includes data analysis on the satisfaction level of different instruments (by brand), pricing analysis of preferred instruments, accessories & components, and consumables. The study is majorly centered on the sub-segments and micro-segments of the different product markets, such as consumables and instruments. The consumables are further categorized into kits and reagents.

To emphasize the dominance of the consumable segment over the instruments segment under the product category of single-cell multi-omics market in 2020 and 2025, Nitish Kumar Singh, Principal Analyst – BIS Research, states, "The reason for market growth and the can be attributed to the large-scale research and development and recent advancement in sequencing technologies aiding researchers to unravel translational and transcription events at a single-cell resolution, attracting many molecular diagnostics and pharma giants to expand their portfolios in this sector."

Request for a Sample: https://bisresearch.com/requestsample?id=1061&type=download

Key insights are drawn from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants, and vendors. The key players profiled in the report include NanoString Technologies, Inc., RareCyte, Inc., Fluidigm Corporation, 10x Genomics, Inc., Becton, Dickinson and Company, Thermo Fisher Sciences, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Namocell, Inc., 1Cell Bio, Inc., Mission Bio, Berkeley Lights, Takara Bio, Inc., Dolomite Bio, and Bio-Techne Corporation. The report also contains company profiles of five emerging players, namely Proteona, BioTuring Inc., Scipio Biosciences SAS, Parse Biosciences, Inc., and Shilps Sciences.

The study also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.

BIS Research provides premium market intelligence on deep technologies that have the potential to cause a high-level of disruption in the market in the next few years. BIS Research excels in conducting market viability analysis for technologies that